SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067849
Filing Date
2023-08-15
Accepted
2023-08-15 17:00:35
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_180lifescien.htm   iXBRL 10-Q 776607
2 CERTIFICATION f10q0623ex31-1_180lifescien.htm EX-31.1 11042
3 CERTIFICATION f10q0623ex31-2_180lifescien.htm EX-31.2 10884
4 CERTIFICATION f10q0623ex32-1_180lifescien.htm EX-32.1 3318
5 CERTIFICATION f10q0623ex32-2_180lifescien.htm EX-32.2 3257
6 GRAPHIC image_001.jpg GRAPHIC 3725
  Complete submission text file 0001213900-23-067849.txt   4854992

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20230630.xsd EX-101.SCH 55392
8 XBRL CALCULATION FILE atnf-20230630_cal.xml EX-101.CAL 29705
9 XBRL DEFINITION FILE atnf-20230630_def.xml EX-101.DEF 244096
10 XBRL LABEL FILE atnf-20230630_lab.xml EX-101.LAB 484837
11 XBRL PRESENTATION FILE atnf-20230630_pre.xml EX-101.PRE 258678
54 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_180lifescien_htm.xml XML 574450
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 231175632
SIC: 2834 Pharmaceutical Preparations